An Agile Scientific Strategy for Global Health: Cochrane’s Future Direction
Emma Persad, Karolinska Institutet
Tamara Kredo, South African Medical Research Council
Roses Parker, Cochrane Collaboration
Bey-Marrie Schmidt, Health Systems Research Unit, African Medical Research Council
Karla Soares-Weiser, Cochrane
Cochrane, globally recognized as a trusted health evidence producer, is paving the way for the future by embracing transformative changes aimed at enhancing its global health impact. This Special Session at the Cochrane Colloquium will shed light on these transformative changes and demonstrate how they establish a pathway towards a pioneering scientific strategy.
Underlining the need for adaptability, Cochrane is recalibrating its processes and methods to enhance experiences for both authors and users of Cochrane evidence. These transformational shifts, although substantial, are integral to maintaining the organization’s relevance and influence in the dynamic global health landscape.
At the core of these transformations is a strategic emphasis on 20 thematic areas that align with the health-related objectives of the United Nations Sustainable Development Goals (SDGs). Collaborating with a range of stakeholders, Cochrane aspires to generate trusted evidence syntheses and champion their worldwide application, aiming for improved health outcomes globally and promoting equity, diversity, and inclusion.
This session will outline the critical steps towards developing this scientific strategy, including a detailed overview of the transformational changes in progress. It will also offer an opportunity to delve into the focus on the Sustainable Development Goals (SDGs) and initiate a broader consultation process to select key themes. The session represents an invitation to engage with Cochrane’s ambitious vision for global health and its commitment to fostering a culture of evidence-informed health and care worldwide.
Target audience: Everyone